|

CBX-12 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Cybrexa Therapeutics1

Indications

  • Refractory Ovarian Carcinoma1
  • Platinum-resistant Ovarian Cancer1
  • Cancer1

Scottsdale, Arizona1 trial

A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian Cancer

Honor Health

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.